NCT00783965View on ClinicalTrials.gov

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

June 30, 2012

Study Completion Date

January 31, 2014

Conditions
Skin Carcinoma
Interventions
DRUG

tazarotene

Applied to the skin

OTHER

placebo

Applied to the skin

Trial Locations (3)

10032

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York

94609

Children's Hospital Oakland Research Institiute, Oakland

94609-1693

Children's Hospital Oakland Research Institute, Oakland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

UCSF Benioff Children's Hospital Oakland

OTHER

NCT00783965 - Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back | Biotech Hunter | Biotech Hunter